Lactobacillus acidophilus

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Lactobacillus acidophilus
DrugBank Accession Number
DB15823
Background

Not Available

Type
Biotech
Groups
Approved, Experimental
Synonyms
  • Acidophilus
  • Bacillus acidophilus whole
  • Bacterium acidophilum whole
  • Lacteol
  • Lactobacillus acidophilus
  • Lactobacillus acidophilus whole
  • Lactobacterium acidophilum whole
  • Thermobacterium intestinale whole

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Probiata TabletsTablet1 bOralPurity Life Health Products A Division Of Sunopta Inc.2001-09-012007-07-26Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Acidophilus Bifidum BulgaricusLactobacillus acidophilus (120 mg) + Bifidobacterium bifidum (120 mg) + Lactobacillus delbrueckii bulgaricus (120 mg)CapsuleOralNutraceutical Corporation2003-09-022006-08-02Canada flag
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 12 ADETLactobacillus acidophilus (50 mg) + Estriol (0.03 mg)SuppositoryVaginalABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 6 ADETLactobacillus acidophilus (50 mg) + Estriol (0.03 mg)SuppositoryVaginalABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
ไกโนฟลอร์Lactobacillus acidophilus (100000000 cfu) + Estriol (0.03 mg)TabletVaginalบริษัท ดีเคเอสเอช (ประเทศไทย) จำกัด2011-09-16Not applicableThailand flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
1PRR1V42V5
CAS number
68333-16-4

References

General References
Not Available
RxNav
6205
Wikipedia
Lactobacillus_acidophilus

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingTreatmentDiarrhoea Predominant Irritable Bowel Syndrome1
4CompletedOtherAllergic Rhinitis (Disorder)1
4CompletedTreatmentBacterial Vaginosis (BV) / Recurrences1
4Not Yet RecruitingTreatmentBasal Ganglia Diseases / Brain Diseases / Central Nervous System Diseases / Movement Disorders / Nervous System Diseases / Neurodegenerative Disorders / Parkinson's Disease (PD) / Parkinsonian Disorders1
4Not Yet RecruitingTreatmentProbiotics / Type 1 Diabetes Mellitus1
4Not Yet RecruitingTreatmentType 2 Diabetes Mellitus With Complication1
4RecruitingTreatmentRecurrent Vulvovaginal Candidiasis1
4Unknown StatusPreventionUrinary Tract Infection1
4Unknown StatusTreatmentBacterial Vaginosis (BV)1
4WithdrawnTreatmentAntibiotics Associated Colitis / Clostridium Difficle Colitis / Enterocolitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Powder, for suspensionOral
CapsuleOral8000000000 [CFU]/1
CapsuleOral16000000000 [CFU]/1
TabletVaginal66.667 mg
TabletVaginal
SuppositoryVaginal
TabletOral
CapsuleOral20000000000 [CFU]/1
TabletVaginal
TabletOral1 b
CapsuleOral
CapsuleOral2 b / cap
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on September 10, 2020 16:02 / Updated on September 13, 2020 19:13